Literature DB >> 26688679

Emerging Role of Hypofractionated Radiotherapy with Simultaneous Integrated Boost in Modern Radiotherapy of Breast Cancer.

Mirko Nitsche1, Juergen Dunst2, Ulrich M Carl3, Robert M Hermann4.   

Abstract

Hypofractionated radiotherapy for breast cancer is becoming increasingly important. The scientific background of this development as well as the introduction of the simultaneous integrated boost to the primary tumor region in this context are discussed here.

Entities:  

Keywords:  Breast cancer; Hypofractionation; Radiotherapy

Year:  2015        PMID： 26688679      PMCID： PMC4677707          DOI： 10.1159/000436951

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


  22 in total

1.  Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapy.

Authors:  A L Bane; T J Whelan; G R Pond; S Parpia; G Gohla; A W Fyles; J-P Pignol; K I Pritchard; S Chambers; M N Levine
Journal:  Ann Oncol       Date:  2014-02-20       Impact factor: 32.976

2.  Long-term results of hypofractionated radiation therapy for breast cancer.

Authors:  Timothy J Whelan; Jean-Philippe Pignol; Mark N Levine; Jim A Julian; Robert MacKenzie; Sameer Parpia; Wendy Shelley; Laval Grimard; Julie Bowen; Himu Lukka; Francisco Perera; Anthony Fyles; Ken Schneider; Sunil Gulavita; Carolyn Freeman
Journal:  N Engl J Med       Date:  2010-02-11       Impact factor: 91.245

3.  Early-stage breast cancer treated with 3-week accelerated whole-breast radiation therapy and concomitant boost.

Authors:  Manjeet Chadha; Rudolph Woode; Jussi Sillanpaa; David Lucido; Susan K Boolbol; Laurie Kirstein; Michael P Osborne; Sheldon Feldman; Louis B Harrison
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-01-04       Impact factor: 7.038

4.  Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial.

Authors:  John Yarnold; Anita Ashton; Judith Bliss; Janis Homewood; Caroline Harper; Jane Hanson; Jo Haviland; Søren Bentzen; Roger Owen
Journal:  Radiother Oncol       Date:  2005-03-16       Impact factor: 6.280

Review 5.  Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline.

Authors:  Benjamin D Smith; Soren M Bentzen; Candace R Correa; Carol A Hahn; Patricia H Hardenbergh; Geoffrey S Ibbott; Beryl McCormick; Julie R McQueen; Lori J Pierce; Simon N Powell; Abram Recht; Alphonse G Taghian; Frank A Vicini; Julia R White; Bruce G Haffty
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-16       Impact factor: 7.038

6.  Hypofractionation with simultaneous integrated boost for early breast cancer: results of the German multicenter phase II trial (ARO-2010-01).

Authors:  Kathrin Dellas; Reinhard Vonthein; Jörg Zimmer; Stefan Dinges; Alexander D Boicev; Peter Andreas; Dorothea Fischer; Cornelia Winkler; Andreas Ziegler; Jürgen Dunst
Journal:  Strahlenther Onkol       Date:  2014-04-16       Impact factor: 3.621

7.  Long-term mortality from cardiac causes after adjuvant hypofractionated vs. conventional radiotherapy for localized left-sided breast cancer.

Authors:  Elisa K Chan; Ryan Woods; Sean Virani; Caroline Speers; Elaine S Wai; Alan Nichol; Mary L McBride; Scott Tyldesley
Journal:  Radiother Oncol       Date:  2014-09-13       Impact factor: 6.280

Review 8.  [Alpha/beta ratio revisited in the era of hypofractionation].

Authors:  C Hennequin; B Dubray
Journal:  Cancer Radiother       Date:  2013-08-22       Impact factor: 1.018

9.  The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.

Authors:  Joanne S Haviland; J Roger Owen; John A Dewar; Rajiv K Agrawal; Jane Barrett; Peter J Barrett-Lee; H Jane Dobbs; Penelope Hopwood; Pat A Lawton; Brian J Magee; Judith Mills; Sandra Simmons; Mark A Sydenham; Karen Venables; Judith M Bliss; John R Yarnold
Journal:  Lancet Oncol       Date:  2013-09-19       Impact factor: 41.316

Review 10.  Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

Authors:  S Darby; P McGale; C Correa; C Taylor; R Arriagada; M Clarke; D Cutter; C Davies; M Ewertz; J Godwin; R Gray; L Pierce; T Whelan; Y Wang; R Peto
Journal:  Lancet       Date:  2011-10-19       Impact factor: 79.321
View more
  7 in total

Review 1.  Recent advances in radiation oncology.

Authors:  Cristina Garibaldi; Barbara Alicja Jereczek-Fossa; Giulia Marvaso; Samantha Dicuonzo; Damaris Patricia Rojas; Federica Cattani; Anna Starzyńska; Delia Ciardo; Alessia Surgo; Maria Cristina Leonardi; Rosalinda Ricotti
Journal:  Ecancermedicalscience       Date:  2017-11-30

Review 2.  Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward.

Authors:  David Krug; René Baumann; Stephanie E Combs; Marciana Nona Duma; Jürgen Dunst; Petra Feyer; Rainer Fietkau; Wulf Haase; Wolfgang Harms; Thomas Hehr; Marc D Piroth; Felix Sedlmayer; Rainer Souchon; Vratislav Strnad; Wilfried Budach
Journal:  Strahlenther Onkol       Date:  2021-01-28       Impact factor: 3.621

3.  Treatment of intracranial neoplasia in dogs using higher doses: A randomized controlled trial comparing a boosted to a conventional radiation protocol.

Authors:  Chris Staudinger; Valeria Meier; Katrin Beckmann; Maximilian Körner; Carla Rohrer Bley
Journal:  J Vet Intern Med       Date:  2022-06-30       Impact factor: 3.175

4.  Advantages of a technique using two 50 degree arcs in simultaneous integrated boost radiotherapy for left-sidebreast cancer.

Authors:  Dan Xi; Yun Ding; Rui Hu; Wendong Gu; Jinming Mu; Qilin Li
Journal:  Sci Rep       Date:  2017-11-07       Impact factor: 4.379

5.  Effect of Clinical and Treatment Factors on Survival Outcomes of Triple Negative Breast Cancer Patients.

Authors:  Shelly Wen; Lucy Manuel; Moira Doolan; Justin Westhuyzen; Thomas P Shakespeare; Noel J Aherne
Journal:  Breast Cancer (Dove Med Press)       Date:  2020-03-06

Review 6.  Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer.

Authors:  James Meehan; Mark Gray; Carlos Martínez-Pérez; Charlene Kay; Lisa Y Pang; Jennifer A Fraser; Amy V Poole; Ian H Kunkler; Simon P Langdon; David Argyle; Arran K Turnbull
Journal:  Front Oncol       Date:  2020-04-24       Impact factor: 6.244

7.  Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer.

Authors:  David Krug; Christine Köder; Matthias F Häfner; Nathalie Arians; Semi B Harrabi; Stefan A Koerber; Tobias Forster; Ingmar Schlampp; Christof Sohn; Joerg Heil; Holger Hof; Juliane Hörner-Rieber; Jürgen Debus
Journal:  Radiat Oncol       Date:  2020-10-13       Impact factor: 3.481
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.